1 Introduction
1.1 What Is This Report About?
1.2 Hematological Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Hematological Disorders Market, India
2.1 Hematological Disorders Market, India, Revenue ($m), 2024-2036
2.1.1 Hematology Tests Market, India, Revenue ($m), by Segment, 2024-2036
2.1.2 Hemostasis Tests Market, India, Revenue ($m), by Segment, 2024-2036
2.2 Hematological Disorders Market, India, Volume (Units), 2024-2036
2.2.1 Hematology Tests Market, India, Volume (Units), by Segment, 2024-2036
2.2.2 Hemostasis Tests Market, India, Volume (Units), by Segment, 2024-2036
2.3 Hematological Disorders Market, India, Average Price ($), 2024-2036
2.4 Hematological Disorders Market, India, Company Share by Revenue ($m), 2025
3 Hematological Disorders Market Pipeline Products
3.1 Hematological Disorders Market Pipeline Products
3.2 Hematological Disorders - Pipeline Products by Stage of Development
3.3 Hematological Disorders - Pipeline Products by Segment
3.4 Hematological Disorders - Pipeline Products by Territory
3.5 Hematological Disorders - Pipeline Products by Regulatory Path
3.6 Hematological Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in India, Hematological Disorders Market
4.1 Sysmex Corp
4.1.1 Company Overview
4.2 Roche Diagnostics International Ltd
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Horiba Ltd Error! Bookmark not defined.
4.4.1 Company Overview Error! Bookmark not defined.
4.5 Radiometer Medical ApS Error! Bookmark not defined.
4.5.1 Company Overview Error! Bookmark not defined.
4.6 Siemens AG Error! Bookmark not defined.
4.6.1 Company Overview Error! Bookmark not defined.
4.7 Diagnostica Stago SAS Error! Bookmark not defined.
4.7.1 Company Overview Error! Bookmark not defined.
4.8 EKF Diagnostics Holdings Plc Error! Bookmark not defined.
4.8.1 Company Overview Error! Bookmark not defined.
4.9 Siemens Healthineers AG Error! Bookmark not defined.
4.9.1 Company Overview Error! Bookmark not defined.
4.10 Instrumentation Laboratory Co Error! Bookmark not defined.
4.10.1 Company Overview Error! Bookmark not defined.
4.11 Thermo Fisher Scientific Inc Error! Bookmark not defined.
4.11.1 Company Overview Error! Bookmark not defined.
4.12 Tulip Diagnostics Pvt Ltd Error! Bookmark not defined.
4.12.1 Company Overview Error! Bookmark not defined.
5 Recent Developments
5.1 Corporate Communications
5.1.1 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors
5.1.2 Oct 29, 2025: Regenerative Medicine Also Known As Stem Cell Therapy
5.1.3 Sep 11, 2025: Navignostics Chosen as Finalist for 2025 Swiss Technology Award
5.2 Other Significant Developments
5.2.1 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors
5.3 Product News
5.3.1 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
5.3.2 Nov 17, 2025: ScreenCell Standardizes CTC Isolation Kits to Two Filtration Units
5.3.3 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
5.4 Research And Development
5.4.1 Feb 04, 2026: Advancing Early Detection for Kidney Disease in Sickle Cell
5.5 Strategy And Business Planning
5.5.1 Nov 13, 2025: Teijin And URAT Partner To Expand Regenerative Medicine And Implantable Medical Devices In Japan And India
5.5.2 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Hematological Disorders Market, India, Revenue ($m), USD Constant, 2024-2036
Table 2: Hematology Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Table 3: Hemostasis Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Table 4: Hematological Disorders Market, India, Volume (Units), 2024-2036
Table 5: Hematology Tests Market, India, Volume (Units), 2024-2036
Table 6: Hemostasis Tests Market, India, Volume (Units), 2024-2036
Table 7: Hematological Disorders Market, India, Average Price ($), 2024-2036
Table 8: Hematological Disorders Market, India, Company Share by Revenue ($m), USD Constant, 2025
Table 9: Hematological Disorders Market Pipeline Products
Table 10: Hematological Disorders - Pipeline Products by Stage of Development
Table 11: Hematological Disorders Companies - Pipeline Products by Stage of Development
Table 12: Hematological Disorders - Pipeline Products by Segment
Table 13: Hematological Disorders - Pipeline Products by Territory
Table 14: Hematological Disorders - Pipeline Products by Regulatory Path
Table 15: Hematological Disorders - Pipeline Products by Estimated Approval Date
Table 16: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hematological Disorders Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 2: Hematology Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hemostasis Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 4: Hematological Disorders Market, India, Volume (Units), 2024-2036
Figure 5: Hematology Tests Market, India, Volume (Units), 2024-2036
Figure 6: Hemostasis Tests Market, India, Volume (Units), 2024-2036
Figure 7: Hematological Disorders Market, India, Company Share (%), 2025
Figure 8: Hematological Disorders - Pipeline Products by Stage of Development
Figure 9: Hematological Disorders - Pipeline Products by Segment
Figure 10: Hematological Disorders - Pipeline Products by Territory
Figure 11: Hematological Disorders - Pipeline Products by Regulatory Path
Figure 12: Hematological Disorders - Pipeline Products by Estimated Approval Date